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Carotid body tumors (CBTs) are neuroendocrine tumors that arise due to mutations of respiratory cycle enzymes.
Fibromuscular dysplasia (FMD) is a disease that causes narrowing of medium-sized arteries. There is no documented link
between CBT and FMD. In this article, we report a case of a patient with bilateral carotid FMD and familial CBT,
including one in an identical twin who underwent successful surgical excision of the CBT. We describe specific
considerations in the management of CBT in patients with concomitant carotid FMD. Also, we review the literature
about the genetics of familial CBT and its possible relationship to the etiology of FMD. (J Vasc Surg 2010;52:746-50.)Carotid body tumors (CBTs) are the most common
type of paragangliomas. They are rare, slow-growing tu-
mors that arise from neural crest cells associated with the
autonomic ganglia. CBTs are usually located at the bifur-
cation of the common carotid artery and are only malignant
in 5% to 7% of cases.1 In familial CBT, mutations in genes
that encode the succinate dehydrogenase (SDH) complex
are inherited in an autosomal dominant pattern. Fibromus-
cular dysplasia (FMD) is a disease of the medium-sized
arteries that leads to narrowing of the arterial lumen, typi-
cally affecting women under the age of 50.2 We present an
interesting case of a patient with left CBT with bilateral
carotid FMD who has a family history of CBTs in three
sisters, including one in an identical twin.
CASE REPORT
A 54-year-old female found a mass on the left side of her neck
during self-examination. The patient was asymptomatic with no
significant medical history. The patient has a family history signif-
icant for an identical twin that underwent excision of a CBT at the
age of 35, a second sister with recent excision of a CBT, and a third
sister recently diagnosed with CBT awaiting surgical treatment.
There were no other relatives with a history of neuroendocrine
tumors. No other family was ever evaluated for FMD. On physical
examination, the patient was normotensive with normal pulses
bilaterally throughout. Examination of the neck revealed a 3-cm
firm, symmetric, mobile, nontender mass on the left side of the
neck immediately medial to the sternocleidomastoid muscle. No
carotid bruits were present on auscultation. The rest of the exam-
ination was normal.
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746Computed tomography (CT) of the neck revealed a 3-cm hyper-
vascular mass superior to the pharyngeal artery resulting in splaying of
the internal and external carotid arteries (Fig 1). OnCT angiography,
the midportion of the internal carotid arteries showed a beaded
contour with several outpouchings, findings indicative of FMD
(Fig 2). CT of the abdomen and pelvis revealed no evidence of
paragangliomas or FMD elsewhere in the body. The patient was
prescribed aspirin for management of asymptomatic FMD.
As part of the preoperative planning, we considered possible
ligation of the left internal carotid artery (ICA) due to the potential
of arterial dissection during mobilization and resection of the
CBT. Balloon occlusion testing demonstrated no electroencepha-
lography or somatosensory-evoked potential changes during oc-
clusion of the left ICA. There was no evidence of stenoses or
aneurysms in the cerebral arteries. Therefore, ligation was consid-
ered to be feasible if necessary. Interposition vein and polytetra-
fluoroethylene grafts were also considered, but given the extensive
FMD in the carotid arteries, it was determined that finding a
suitable location for distal attachment of the graft would be diffi-
cult. Endocrine workup, including serum parathyroid hormone,
calcitonin levels, 24-hour urine metanephrine, normetanephrine,
homovanillic acid, and vanillylmandelic acid collections revealed
that the mass was nonfunctional with no evidence of multiple
endocrine neoplasia syndrome or pheochromocytoma.
The patient underwent successful excision of the left CBT
(Figs 3 and 4). Careful circumferential dissection of the CBT in the
adventitial plane of the common carotid artery allowed exposure of
the mass with preservation of the ICA. The superior thyroidal and
superior pharyngeal branches of the external carotid artery supply-
ing the CBT were identified and divided. Doppler ultrasound scan
used intraoperatively demonstrated normal signals from the com-
mon carotid, internal carotid, and external carotid arteries before
and after tumor excision. Meticulous hemostasis was maintained
and cranial nerves were carefully identified throughout the proce-
dure. Histology of the excised mass demonstrated a “Zellballen”
growth pattern containing atypical cells with high mitotic activity,
characteristics seen in paragangliomas.
The patient had no neurologic sequelae and was discharged
home on postoperative day 1. At 3-month follow-up, the patient
continued to do well without any symptoms. Duplex ultrasound
demonstrated elevated velocities and turbulence in the distal ICAs
and, interestingly, in the renal arteries as well, indicative of carotid
tumors superior to bifurcation of the common carotid artery.
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by the tumor with outpouchings in the middle and distal internal carotid artery. B, Angiogram (small arrows): superior
thyroidal and superior pharyngeal arteries supplying the carotid body tumor. “Beading” and outpouchings of theFig 1. A and B, Three-dimensional reconstruction of computed tomography scans demonstrating left carotid bodyinternal carotid artery (large arrow) consistent with fibromuscular dysplasia.
A) an
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DISCUSSION
CBTs represent the most common type of parasympa-
thetic paragangliomas, rare tumors that arise from neu-
roendocrine cells. Although CBTs can cause hoarseness
and Horner’s syndrome from direct pressure on the vagus
or sympathetic nerves, CBTs are most often painless and
asymptomatic.3,4 Surgical resection remains the preferred
treatment for CBTs.5 However, CBTs larger than 5 cm
have a 67% risk of increased morbidity and mortality result-
ing from damage to nearby vessels and nerves.6 In these
instances, particular caution must be used during dissec-
tion. Because new paragangliomas can arise and excised
paragangliomas can recur, long-term follow-up of even
Fig 3. Intraoperative images from before (apparently benign paragangliomas is necessary to deter-mine the success of treatment. The appearance ofmetastasis
has been reported from 20months to 20 years after surgical
resection.7
Approximately 10% to 50% of paragangliomas are in-
herited either as part of syndromes such as multiple endo-
crine neoplasia II, neurofibromatosis I, and von Hippel-
Lindau disease, or as defects in genes encoding the SDH
complex, a mitochondrial enzyme needed for the respira-
tory cycle.8,9 Mutations in subunits B, C, and D have been
identified, with SDH D defects accounting for 71% of all
cases. SDH B defects lead to higher malignancy rates when
compared with other hereditary and sporadic paraganglio-
mas.10 SDHB andDmutations have also been described in
cases of sporadic pheochromocytomas in patients with no
family history of them, suggesting that thesemutationsmay
exhibit incomplete penetrance in certain patients increasing
d after (B) excision of carotid body tumor.their risk for CBTs.11
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der that predominantly affects women and leads to the
development of arterial stenosis, most commonly in renal
arteries (60% to 75%) and ICAs (25% to 30%).12,13 Affected
arterial walls demonstrate either intimal fibroplasia, medial
fibroplasia, or adventitial fibroplasia. Medial fibroplasias
comprise the majority of FMD cases and may be diagnosed
on angiography by identifying the characteristic ‘string of
beads’ appearance.14 Extracranial FMD of the ICA is most
often asymptomatic, but when symptomatic and untreated,
Fig 4. A, Gross image of the tumor. Histological analysis dem-
onstrates (B) “Zellballen” growth pattern (arrow) characteristic of
carotid body tumors and (C) atypical cells with high mitotic
activity (arrows).it can cause transient ischemic attacks, strokes, intracerebralhemorrhages, and carotid artery dissection.12,15 Overall,
patients with carotid FMD have a favorable prognosis.
Asymptomatic patients can be maintained safely on an
antiplatelet agent such as aspirin.16 For symptomatic pa-
tients, technical success and favorable outcomes have been
reported with percutaneous transluminal angioplasty, with
the added benefits of shorter recovery periods and de-
creased complication rates than open surgery.17-19
The etiology of FMD remains unclear, although many
potential causes, including mechanical and hormonal fac-
tors, have been implicated. Multiple case reports have also
described renal FMD in twins or first-degree relatives,
suggesting that genetics also play a role in disease develop-
ment. Studies have suggested that FMD is inherited in an
automosomal-dominant pattern, manifesting a variety of
clinical symptoms due to incomplete penetrance.20 The
specific genes involved have yet to be identified.
To our knowledge, this is the first case of concomitant
CBT and FMD in the literature. There is no documented
anatomic or genetic link between the pathogenesis of CBT
and FMD. Diagnostic studies for FMD in the patient’s
family members may be of particular interest given the
extensive history of CBT. Further investigation is needed to
determine whether there is a link between CBT and FMD,
or if this case represents a statistical rarity. However, we
have established that with careful surgical technique, safe
excision of CBT can be accomplished in patients with
ipsilateral carotid FMD.
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